Pulse Biosciences, Inc.
PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company wasā¦ read more
Healthcare
Medical Instruments & Supplies
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$52.97
Price+8.57%
$4.18
1Y
Price
Market Cap
$3.666b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-5681.3%
EBITDA Margin-5681.3%
Net Profit Margin-4331.6%
Free Cash Flow Margin-5681.3%
EBITDA Margin-5681.3%
Net Profit Margin-4331.6%
Free Cash Flow MarginRevenue
$1.185m
+238.6%
1y CAGR+79.5%
3y CAGR+34.6%
5y CAGREarnings
-$80.056m
-10.0%
1y CAGR-24.3%
3y CAGR-11.2%
5y CAGREPS
-$1.17
-8.3%
1y CAGR-10.1%
3y CAGR+4.6%
5y CAGRBook Value
$99.500m
$115.564m
Assets$16.064m
Liabilities$6.772m
DebtDebt to Assets
5.9%
-0.1x
Debt to EBITDAFree Cash Flow
-$61.388m
-12.8%
1y CAGR-24.0%
3y CAGR-10.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company